SYN – Evistyn 30 – Raloxifene (Evista) – 60 x 30mg

What is Raloxifene (Evista) by SYN Pharma?

Raloxifene, sold under the name Evista, is a second-generation selective estrogen receptor modulator (SERM) used in research for its ability to block estrogen in specific tissues while activating it in others. Most notably, Raloxifene is effective in treating or preventing gynecomastia by blocking estrogen receptors in breast tissue, making it a valuable tool for on-cycle and post-cycle support.

SYN Pharma’s Raloxifene tablets are dosed at 30 mg and supplied in 60-count bottles, offering a full cycle’s worth of flexible estrogen management without impacting liver function or testosterone production directly.

Benefits of Raloxifene

• Prevents or reverses early-stage gynecomastia
• Blocks estrogen at breast tissue receptor sites
• Supports post-cycle estrogen control
• Does not reduce systemic estrogen or suppress testosterone

Active Ingredient Per Tablet

• Raloxifene Hydrochloride – 30 mg

Dosage and Administration

Raloxifene is commonly used at a dose of 30 to 60 mg per day depending on severity of symptoms. For mild to moderate gynecomastia, 60 mg daily for the first 2 weeks followed by 30 mg daily for another 2 to 4 weeks is often sufficient.

Raloxifene is most effective when used at the first sign of gyno symptoms such as nipple sensitivity or puffiness. It may also be used as a preventative measure in estrogen-sensitive users during cycles involving aromatizing compounds.

Standard Gyno Reversal Protocol

Common Questions About Raloxifene

Is Raloxifene better than Nolvadex for gyno?

Many users report that Raloxifene is more effective at reversing existing gynecomastia, while Nolvadex is more commonly used for post-cycle recovery. Raloxifene may offer better tissue-specific activity with fewer side effects.

Can Raloxifene be used with an AI?

Yes. While Raloxifene blocks estrogen at the receptor, AIs reduce systemic estrogen production. When estrogen levels are high and gyno is forming, combining the two can be more effective than either alone.

Does Raloxifene reduce estrogen levels?

No. It does not lower circulating estrogen. Instead, it blocks estrogen from binding in specific tissues like breast tissue, which is ideal for treating or preventing gyno without affecting overall hormonal balance.

Can women use Raloxifene?

Raloxifene was originally developed for use in postmenopausal women to support bone density and reduce breast cancer risk. However, SYN Pharma’s product is intended for research purposes only and not for human consumption.